Novo Integrated Sciences Acquires Clinical Consultants International LLC

Novo Integrated Sciences Acquires PRO-DIP, LLC

May 26, 2021

Medical Devices

Novo Integrated Sciences (NASDAQ: NVOS) completed an all-share acquisition of PRO-DIP, LLC, a San Jose-based developer of a patent-pending oral pouch delivery system for nutraceutical and medicinal formulations. The transaction (valued at $755,385 or $3.98 per share) expands Novo's health-science IP portfolio and adds product capabilities and distribution relationships to support nutraceutical and medical product applications.

Novotech Acquires US-based Regulatory Consulting Firm CBR International

January 9, 2023

Healthcare Services

Novotech, an Asia-Pacific–focused clinical research organization (CRO), has acquired US-based regulatory and drug development consultancy CBR International. The acquisition strengthens Novotech's US FDA regulatory, scientific and clinical development capabilities to better support biotech and pharma clients across the US, Europe and Asia-Pacific.

Novo Integrated Sciences / Novo Healthnet Acquire Acenzia Inc.

June 29, 2021

Pharmaceuticals

Novo Integrated Sciences, through its wholly owned subsidiary Novo Healthnet Limited, completed the acquisition of Acenzia Inc., a Windsor, Ontario-based nutraceutical manufacturer and diagnostics developer. The all-share transaction closed on June 24, 2021 and is valued at $14,884,039; Novo said the purchase will give it direct control of development, manufacturing and distribution of wellness products and personalized diagnostics.

Novo Holdings Acquires Altasciences from Audax Private Equity

February 22, 2021

Healthcare Services

Novo Holdings has agreed to acquire Altasciences, a Laval, Canada–headquartered contract research and CDMO services provider, from Audax Private Equity. Altasciences— which operates six facilities across the U.S. and Canada and employs over 1,300 people—will remain led by CEO Chris Perkin and is expected to continue expanding domestically and internationally under Novo Holdings' ownership.

Inotiv Acquires Integrated Laboratory Systems (ILS)

January 10, 2022

Healthcare Services

Inotiv, Inc. (NASDAQ: NOTV) completed the acquisition of Integrated Laboratory Systems, LLC (ILS), a contract research organization based in Morrisville, North Carolina, from Sier Capital. The transaction consideration totaled $56.0 million (approximately $38.0 million cash and 429,118 Inotiv shares valued at $18.0 million); ILS reported roughly $20.0 million of revenue in 2021 and will be integrated to expand Inotiv's genetic toxicology, in vivo/in vitro toxicology, pathology, genomics, and computational toxicology capabilities.

Sciens Building Solutions Acquires Open Systems Integrators (OSI)

June 19, 2024

Engineering Services

Sciens Building Solutions, a Carlyle-backed life-safety platform, has acquired Open Systems Integrators (OSI), a Hamilton, New Jersey-based provider of low‑voltage fire, security and AV systems. OSI's CEO Paul Facciolo will remain in place as the company expands Sciens' Northeast footprint and service capabilities across education, healthcare, government and commercial markets.